NUTEX HEALTH INC (NUTX)
US67079U3068 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 18.794M 1,084.99% | 219.294M 1,066.83% | 247.646M 12.93% | 309.55M 25.00% | 354.13M 14.40% | 392.76M 10.91% | |
| EBITDA YoY % growth | -8.304M -143.45% | 8.553M 203.00% | 16.3M 90.58% | 39.265M 140.89% | 44.528M 13.40% | 48.645M 9.25% | |
| EBIT YoY % growth | -9.018M -156.12% | -4.578M 49.23% | -1.292M 71.78% | 24.272M 1,978.64% | 36.964M 52.29% | 40.974M 10.85% | |
| Operating Margin | -47.98% | -2.09% | -0.52% | 7.84% | 10.44% | 10.43% | |
| EPS YoY % growth | N/A | N/A | -4.50 95.61% | -2.06 54.14% | 1.27 161.45% | 2.14 68.90% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.13 | -0.24 59.20% | 0.38 648.86% | 0.59 134.20% | 0.53 524.33% |
| Revenue Q2Q % growth | 82.748M 18.77% | 83.465M 23.74% | 86.277M 13.40% | 89.092M 13.07% | 95.334M 15.21% |
| EBITDA Q2Q % growth | 8.582M -60.40% | 7.522M 33.46% | 11.898M -42.49% | 13.214M -44.43% | 11.895M 38.60% |
| EBIT Q2Q % growth | 7.536M 84.84% | 3.944M 172.00% | 9.97M -16.71% | 11.366M 12.67% | 11.683M 55.03% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.72 -14.67% | -0.24 | -1.48 | -602.61% |
| Q2 2024 Q2Q % growth | -0.07 95.33% | -0.30 | 0.23 | 76.34% |
| Q1 2024 Q2Q % growth | -0.60 60.00% | 0.00 | -0.60 | % |
| Q4 2023 Q2Q % growth | 0.00 100.00% | 0.00 | 0.00 | % |
| Q3 2023 Q2Q % growth | -1.50 | -0.77 | -0.74 | -96.08% |
| Q2 2023 Q2Q % growth | -1.50 -4,900.00% | -0.77 | -0.74 | -96.08% |
| Q1 2023 Q2Q % growth | -1.50 | -2.30 | 0.79 | 34.64% |
| Q4 2022 Q2Q % growth | -3.00 | -2.30 | -0.71 | -30.72% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 78.795M 25.62% | 74.689M | 4.106M | 5.50% |
| Q2 2024 Q2Q % growth | 76.082M 29.12% | 69.564M | 6.518M | 9.37% |
| Q1 2024 Q2Q % growth | 67.454M 19.75% | 66.096M | 1.358M | 2.05% |
| Q4 2023 Q2Q % growth | 69.669M 29.68% | 72.828M | -3.159M | -4.34% |
| Q3 2023 Q2Q % growth | 62.723M 120.89% | 64.515M | -1.792M | -2.78% |
| Q2 2023 Q2Q % growth | 58.924M 1.51% | 63.291M | -4.367M | -6.90% |
| Q1 2023 Q2Q % growth | 56.329M -28.81% | 57.171M | -842K | -1.47% |
| Q4 2022 Q2Q % growth | 53.724M 807.50% | 50.924M | 2.8M | 5.50% |
| Q3 2022 Q2Q % growth | 28.395M 409.88% | % | ||
| Q2 2022 Q2Q % growth | 58.048M 997.11% | % | ||
| Q1 2022 Q2Q % growth | 79.127M 3,828.85% | % | ||
| Q4 2021 Q2Q % growth | 5.92M 1,410.20% | % | ||
| Q3 2021 Q2Q % growth | 5.569M 1,491.14% | % | ||
| Q2 2021 Q2Q % growth | 5.291M 1,296.04% | % | ||
| Q1 2021 Q2Q % growth | 2.014M 332.19% | % | ||
| Q4 2020 Q2Q % growth | 392K -70.90% | % | ||
| Q3 2020 Q2Q % growth | 350K 79.49% | % | ||
| Q2 2020 Q2Q % growth | 379K -14.83% | % | ||
| Q1 2020 Q2Q % growth | 466K 119.81% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -105.55% | 5.01% | -44.52% |
| Revenue | 0% | 4.81% | 0.03% | 2.25% |